Open Access

ARTICLE

PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1

Yasemin Baskin^*†‡, Gizem Calibasi Kocal^‡§, Betul Bolat Kucukzeybek^¶, Mahdi Akbarpour^#, Nurcin Kayacik^**, Ozgul Sagol^††, Hulya Ellidokuz^†‡‡, Ilhan Oztop^§§

* Institute of Oncology, Department of Basic Oncology, Dokuz Eylul University, Izmir, Turkey
† Faculty of Medicine, Department of Medical Informatics and Biostatistics, Dokuz Eylul University, Izmir, Turkey
‡ Personalized Medicine and Pharmacogenomics/Genomics Research Centre-BIFAGEM, Dokuz Eylul University, Izmir, Turkey
§ Institute of Health Sciences, Department of Basic Oncology, Dokuz Eylul University, Izmir, Turkey
¶ Ataturk Training and Research Hospital, Department of Pathology, Izmir Katip Celebi University, Izmir, Turkey
# German Cancer Research Center, Division of Translational Oncology, Heidelberg, Germany
** Molecular Oncology Laboratory, Dokuz Eylul University Hospital, Izmir, Turkey
†† Faculty of Medicine, Department of Pathology, Dokuz Eylul University, Izmir, Turkey
‡‡ Institute of Oncology, Department of Preventive Oncology, Dokuz Eylul University, Izmir, Turkey
§§ Faculty of Medicine, Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkey